Oct. 14, 2024 — On Oct. 14, GE HealthCare launched Versana Premier, the latest release within the Versana ultrasound family of reliable, affordable, easy-to-use, and versatile ultrasound systems.

Oct. 14, 2024 – The Institute for AI Governance in Healthcare (IAIGH) has published the draft Healthcare AI Governance Standard (HAIGS) for public comment.

The comment period opened Oct. 14, 2024, and closes Nov. 14, 2024.

The draft standard is available for review and feedback at AiHealthcareGovernance.org.

HIMSS will be presenting a webinar on "Addressing the Changing Data Demands of Next-Gen Healthcare" on Nov. 13, 2024 at 1 p.m. Central time.

The delivery of next-generation patient care relies upon seamless access to comprehensive and relevant patient data. However, the proliferation of patient data silos across multiple hosted environments can present significant integration challenges. To ensure that the full potential of next-generation healthcare solutions is realized, healthcare providers must rethink their data strategy.  

A major update was made to the International Nuclear Workers Study (INWORKS), an international epidemiological study of workers in the nuclear sector to assess their risks of cancer and non-cancerous diseases.  

Oct. 3, 2024 — GE HealthCare’s MIM Software has announced it received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to perform absorbed dose calculation of radionuclides using a Monte Carlo method. With this clearance, Monte Carlo dosimetry via the Dose Planning Method (DPM) will be available for use with MIM SurePlan MRT, MIM Software’s comprehensive solution for automating and standardizing dosimetry in Theranostics.  

October 2, 2024 – Owkin recently announce a new partnership with AstraZeneca to develop an AI-powered tool to pre-screen for gBRCA mutations (gBRCAm) in breast cancer directly from digitized pathology slides. As part of Owkin’s ongoing collaboration with Gustave Roussy and The Centre Léon Bérard through PortrAIt, a French consortium to accelerate precision medicine through AI-enabled digital pathology, this tool aims to significantly accelerate and expand access to gBRCA testing that too many patients may not be considered for.

Sept. 30, 2024 – A recent study accepted by the American Society of Radiation Oncology (ASTRO) for their annual meeting in Washington D.C. demonstrates a significant reduction in radiation Planning Target Volume involving patients who received Breast Conserving Surgery (lumpectomy), a VeraForm marker for cavity delineation and Accelerated Partial Breast Irradiation (APBI) along with Deep Inspiration Breath Hold (DIBH) for motion management. 

Oct. 1, 2024 — At ASTRO 2024, Jay Detsky, MD, PhD, radiation oncologist at Sunnybrook Health Sciences Centre (Toronto, Ontario, Canada), presented initial cancer control outcomes from the UNITED trial (Unity-Based MR-Linac Guided Adaptive Radiotherapy for High Grade Glioma).

Oct. 2, 2024 – On Oct. 2, Proscia launched Concentriq Embeddings and the Proscia AI Toolkit, enabling life sciences organizations to accelerate the discovery and development of novel therapies and diagnostics. Integrated into Proscia’s Concentriq platform, Concentriq Embeddings delivers a collection of pathology foundation models to AI developers and research scientists, allowing them to leverage their organization's large proprietary datasets and execute models in routine workflows.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now